Jennifer Lynne Fox - 12 Mar 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: Chief Legal Officer
Issuer ticker: MYGN
Reported as of: 12 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Mar 2026, 17:05:54 UTC
Prior SEC filing: 04 Sep 2025
Source filing: View source filing
Reporting owner signature: By: Justin Hunter For: Jennifer Lynne Fox

Key filing fact

Jennifer Lynne Fox filed Form 4 for MYRIAD GENETICS INC (MYGN) on 16 Mar 2026.

Key facts

This page summarizes Jennifer Lynne Fox's Form 4 filing for MYRIAD GENETICS INC (MYGN).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 16 Mar 2026, 17:05.

Change

Previous filing in this sequence was filed on 04 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001914879 Primary reporting owner

Fox Jennifer Lynne

Relationship: Chief Legal Officer
Address: 322 NORTH 2200 WEST, SALT LAKE CITY
Signature: By: Justin Hunter For: Jennifer Lynne Fox
Signature date: 16 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN transaction

Common Stock

Award

Transaction value
Shares: +195,876
Change %: +163%
Price: $0.000000^*
Shares after: 316,357
Date: 12 Mar 2026
Ownership: Direct
Footnotes: F1

MYGN transaction

Common Stock

Tax liability

Transaction value
Shares: -5,995
Change %: -1.9%
Price: $4.66^*
Shares after: 310,362
Date: 13 Mar 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Footnote F2

Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.